SBSusan A. Barr

Susan A. Barr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Susan A. Barr has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Amanda B. White

    From the *Department of Obstetrics and Gynecology, the University of Arkansas for Medical Sciences, Little Rock, AR; †Division of Female Pelvic Medicine and Reconstructive Surgery, TriHealth, Cincinnati, OH; ‡Department of Women's Health, Dell Medical School at the University of Texas at Austin, Austin, TX; §Valley Urogynecology Associates, University of Arizona, Phoenix, AZ; and ∥Department of Obstetrics and Gynecology, Northwestern Medicine, Chicago, IL

    1 shared publication
  • Amanda Thomas

    Louisiana State University, Baton Rouge, LA, USA

    1 shared publication
  • Catrina C. Md Crisp

    From the *Department of Obstetrics and Gynecology, the University of Arkansas for Medical Sciences, Little Rock, AR; †Division of Female Pelvic Medicine and Reconstructive Surgery, TriHealth, Cincinnati, OH; ‡Department of Women's Health, Dell Medical School at the University of Texas at Austin, Austin, TX; §Valley Urogynecology Associates, University of Arizona, Phoenix, AZ; and ∥Department of Obstetrics and Gynecology, Northwestern Medicine, Chicago, IL

    1 shared publication
  • Clifford F. Melick

    Palm Beach Gardens, FL, USA

    1 shared publication
  • Jeffrey A. Gavard

    Saint Louis University, Saint Louis, MO, USA

    1 shared publication
  • Kimberly Kenton

    From the *Department of Obstetrics and Gynecology, the University of Arkansas for Medical Sciences, Little Rock, AR; †Division of Female Pelvic Medicine and Reconstructive Surgery, TriHealth, Cincinnati, OH; ‡Department of Women's Health, Dell Medical School at the University of Texas at Austin, Austin, TX; §Valley Urogynecology Associates, University of Arizona, Phoenix, AZ; and ∥Department of Obstetrics and Gynecology, Northwestern Medicine, Chicago, IL

    1 shared publication

Latest Publications

  • FACE: Female Pelvic Medicine and Reconstructive Surgery Awareness Campaign: Increasing Exposure

    by Susan A. Barr, Catrina C. Md Crisp, Amanda B. White, Shazia A. Malik, Kimberly Kenton

    Objective: The aims of this study are to identify screening, treatment, and referral practices of primary care physicians (PCPs) for patients with pelvic floor disorders (PFDs) and evaluate awareness of the Female Pelvic Medicine and Reconstructive Surgery (FPMRS) subspecialty. Methods: We conducted a cross-sectional survey of PCPs using a random sample of 1005 American College of Physicians members, stratified by demographic region. Electronic survey content included awareness of FPMRS certification, comfort diagnosing and treating PFDs, and PFD referral patterns for PCPs. Results: The 399 survey respondents were predominately male and of diverse ages, geographic distribution, and experience level. Forty-eight percent were aware of the FPMRS subspecialty, 31% of FPMRS board certification, and 25% of American Urogynecologic Society. Less than one third screened for PFDs, only two thirds were comfortable diagnosing urinary complaints, and even fewer felt comfortable diagnosing pelvic organ prolapse and fecal incontinence (FI). Eighty-five percent recommended pelvic floor exercises for stress urinary incontinence and referred to urology (29%) or FPMRS (25%) as second-line therapy, whereas 55% recommended medication/fiber for FI and referred to gastroenterology/colorectal surgery (31%) and FPMRS (2%) as second-line therapy. Primary care physicians referred to colorectal surgery for FI (60%), to Ob/Gyn for obstetric anal sphincter injury (38%) and pelvic organ prolapse (57%), and to urology for microscopic hematuria (80%), overactive bladder (60%), recurrent urinary tract infection (75%), stress urinary incontinence (48%), and voiding dysfunction (84%). Conclusions: Most PCPs do not routinely screen for PFDs, and fewer feel comfortable treating. The majority is unaware of FPMRS and American Urogynecologic Society and more commonly refers PFD patients to other specialists.


  • Incidence of successful voiding and predictors of early voiding dysfunction after retropubic sling

    by Susan A. Barr, Amanda Thomas, Shannon Potter, Clifford F. Melick, Jeffrey A. Gavard, Mary T. McLennan

    Introduction and hypothesis There is a paucity of literature on resumption of normal voiding predictors after synthetic retropubic sling insertion and lack of a standardized method of determination. Our goals were to determine the incidence of a successful voiding trial; whether clinical, operative, or urodynamic variables predict discharge with a catheter; and incidence of later retention in those who were initially successful. Methods We performed an internal-review-board (IRB)-approved retrospective chart review of 229 consecutive patients who underwent retropubic sling (TVT, Boston Scientific, Natick, MA, USA)) from 2001 to 2010. Exclusions were concomitant surgery or cystotomy at the time of retropubic sling insertion. All participants underwent a voiding trial in recovery consisting of 300 cc sterile-water retrograde fill and were discharged home without a catheter after single void of at least 200 cc following catheter removal. Results Of 170 patients, 136 (80 %) passed the voiding trial the same day, with 165 (97 %) passing within 1 day. Factors associated with delayed voiding were age ≥65 years (p < 0.05), presence of Valsalva voiding (p < 0.01), lower body mass index (BMI) (p < 0.05), and higher gravidity (p < 0.05) and parity (p < 0.01). Age ≥65 years [adjusted odds ratio (aOR) 3.72, 95 % confidence interval (CI) 1.40–9.90, p < 0.01] and Valsalva voiding (aOR 3.89, 95 % CI 1.56–9.69, p < 0.01) remained significant independent predictors in multivariate analysis. Conclusions The majority of patients with retropubic sling can be safely discharged home the same day without a catheter after retrograde fill. Women >65 years or Valsalva voiders had nearly four times the odds of being discharged with a catheter. Summary Most patients resume normal voiding within 24 h after retropubic sling insertion, but >65 years and Valsalva voiding are risk factors for voiding inability at discharge.